Polymorphisms in microRNA Target Sites and Susceptibility to Chronic Obstructive Pulmonary Disease
분야
의약학 > 내과학
저자
이재희 , 최이영 , 이원기 , 유승수 , 이신엽 , 차승익 , 김창호 , 전효성 , 박재용
발행기관
대한결핵 및 호흡기학회
간행물정보
대한결핵및호흡기학회 추계학술발표초록집 2012년, 제114권 227(총1페이지)
파일형식
0y909957.pdf [무료 PDF 뷰어 다운로드]
  • ※ 본 자료는 참고용 논문으로 수정 및 텍스트 복사가 되지 않습니다.
  • 구매가격
    1,000원
    적립금
    30원 (구매자료 3% 적립)
    이메일 발송  스크랩 하기
    자료 다운로드  네이버 로그인
    영문초록
    Background: The stringent recognition requirement between microRNA (miRNA) and its target site suggests that naturally occurring polymorphisms in miRNA target sites might have significant functional implications for miRNA binding and post-transcriptional regulation and consequently affect susceptibility of chronic obstructive pulmonary disease (COPD). Methods: To investigate the influence of putative polymorphisms in miRNAs target sites on COPD, we searched out polymorphisms in miRNA target sites through bioinformatics analysis and conducted a case-control study including 286 patients and 287 healthy controls. Results: Among the 392 polymorphisms of miRNA target sites examined, we found that 5 polymorphisms (GTF3C5 rs7324G> A, NUCB1 rs1058491G>A, C16orf55 rs17177787C>G, ARHGEF15 rs3744649G>T, and PTST1 rs3757417 T>G) had a significant effect on the risk of COPD. In silico analysis revealed that the rs7324 on GTF3C5, rs1058491 on NUCB1, rs3757417 on TPST1, rs17177787 on C16orf55 and rs3744649 on ARHGEF15 were targeted by miR-1469, miR-492, let-7i, has-miR-7-1 and miR-197, respectively. Conclusion: Our findings provide the first evidence that polymorphisms in miRNA target sites could affect susceptibility to COPD.
    사업자등록번호 220-87-87785 대표.신현웅 주소.서울시 서초구 방배로10길 18, 402호 대표전화.070-8809-9397
    개인정보책임자.박정아 통신판매업신고번호 제2017-서울서초-1765호 이메일 help@reportshop.co.kr
    copyright (c) 2009 happynlife. steel All reserved.